Human T lymphocytes express receptors for antigen that are associated in a molecular complex to CD3 surface proteins . In most CD3+ cells these receptor molecules are represented by disulphide-linked heterodimers formed by an a and a 0 chain that recognize antigen(s) in an MHC-restricted fashion (1, 2) . However, another small subset has recently been identified that does not express a/R molecules in association with CD3 (3, 4) . These cells do not react with the WT31 mAb (specific for a framework determinant of the TCR a/a) and do not express CD4 and CD8,
Human T lymphocytes express receptors for antigen that are associated in a molecular complex to CD3 surface proteins . In most CD3+ cells these receptor molecules are represented by disulphide-linked heterodimers formed by an a and a 0 chain that recognize antigen(s) in an MHC-restricted fashion (1, 2) . However, another small subset has recently been identified that does not express a/R molecules in association with CD3 (3, 4) . These cells do not react with the WT31 mAb (specific for a framework determinant of the TCR a/a) and do not express CD4 and CD8, the molecules associated with class II or class I MHC antigen recognition (4) . In these cells, C133-associated molecules are represented by the surface product of the TCRy and -S genes (5) (6) (7) (8) .
Previous studies have indicated that TCRy/S + cells, similarly to cells expressing TCR a/R, can be activated by antibodies directed to surface CD3 or CD2 antigens (9, 10) . However, no direct evidence exists that stimuli acting via the surface receptor itself would result in activation of the functional program of the cells. We have now isolated a mAb reacting with the surface receptor expressed on CD3 + WT31 -cells by immunizing with a cell h.ne derived from human peripheral T cells expressing the CD3+WT31 -CD4-CD8-surface phenotype. This antibody, termed BB3, reacts with a large subset (>60%) of CD3 + WT31 -lymphocytes and immunoprecipitates from the surface of these cells a disulphide-linked dimer associated to CD3 proteins . Treatment of CD3+WT31 -cells with BB3 mAb led to a rapid intracellular Ca" increment and resulted in the induction of the functional program(s) of the cells such as triggering of the lytic machinery and lymphokine production .
This work was supported in part by grants awarded by the Consiglio Nazionale delle Ricerche (CNR) cell system consisting of the IL-2-responsive murine CTLL cell line as described previously (17) . Data were expressed as arbitrary units of IL-2 activity. One unit was defined as the amount of IL-2 required for the induction of a half-maximal proliferative response by CTLL cells . The cytolytic activity of the clones was tested in a 4-h "Cr-release assay in which CD3' WT31' or CD3' WT31 -cells were used as effector cells against the hybridomas producing anti-CD3, anti-CD2, and BB3 mAbs, respectively. All these target cells were used at 5 x 103 cells/well for a final E/T cell ratio of 10:1 . A second type of cytolytic assay was performed using the murine P815 line as target cell (18) . In this assay 5 x 103 "Cr-labeled target cells were added xo each well containing 5 x 103 effector cells in the presence of either one of the following mAbs : anti-CD3 (20 ul of culture supernatant), BB3 (20 p1 of culture supernatant) and WT31 (20 ul of a 1 :20 dilution of the stock solution) . The final culture volume was 0.2 ml for each well. After a 4-h culture period, 0 .1 ml was removed from each well and counted in a gamma counter for the assessment of "Cr release. Percent specific "Cr release was determined as previously described (19) .
Determination of Free Cytoplasmic Ca' Concentrate'on. Determination of [Ca2+ ] ; was performed as previously described (20) . Briefly, CD3' WT31-cells were loaded with acetoximethyl ester of Fura-2 (1 wM final concentration) and the fluorescence of the cellular suspension (105/2 ml) was monitored with an LS-5 spectrofluorimeter (Perkin-Elmer Corp., Pomona, CA) using 2 ml quartz cuvette . The cell suspension was excited at 340-380 nm and fluorescence measured at 510 nm . Five slit widths were used for both excitation and emission. All measurements were performed at 37'C using a thermostatically controlled cuvette holder and stirring apparatus. [Ca 2* ] ; were calculated by the method of Grynkiewicz et al. (21) . In the Cat' depletion experiments, EGTA (final concentration 10 mM) was added to the cellular suspension from a 500-mM stock (pH 7 .4) 1-10 min before the addition of the stimulatory mAb .
Results and Discussion
Cell Distribution of BB3 Antigenic Determinant . A polyclonal CD3' 4-8-WT31 -cell line termed MVl was used for mice immunization . This cell line was derived from peripheral blood lymphocytes depleted of CD8' and CD4' cells by specific mAbs and complement and cultured in the presence of rIL-2. We have previously shown that the C133-associated molecules expressed in this cell line are likely to be represented by the TCR-y/8 gene products (22) . Among the various hybridoma supernatants tested, one, termed BB3, reacted with the immunizing MV1 line but not with a large panel of TCR-a/R-bearing lymphocyte populations or clones . On the other hand, large proportions of CD3' WT31 -clones, derived from six different donors, reacted with BB3 mAb. For example, 12 of 16 CD3'WT31 -clones derived from one donor and 9 of 12 derived from another donor were BB3' . In addition, BB3 mAb reacted with variable, but usually small, percentages of peripheral blood lymphocytes . These percentages ranged between 0.5 and 8% in 12 different individuals tested and paralleled the percentages of CD3'WT31 -cells, as indicated by twocolor immunofluorescence experiments . A representative experiment is shown in Fig . 1 : 7 % of PBMC were stained by anti-CD3 mAb but were unreactive with WT31 mAb. When the same lymphocyte suspension was analyzed using anti-CD3 in combination with BB3 mAb, 6.6% of the cells were simultaneously stained by the two mAbs. Moreover, BB3' cells were restricted to CD3' cell populations, since no BB3' CD3 -cells could be detected . Taken together, these results indicate that most, but not all, CD3' WT31" peripheral blood lymphocytes are recognized by BB3 rnAb . We next analyzed whether after interaction with the BB3 rnAb, BB3 surface molecules would undergo modulation since such phenomenon has been shown to occur after interaction of TCR-a/0 or CD3 (23, 24) with the respective mAbs . We found that BB3 antigenic determinant was susceptible to mAb-induced surface modulation in a similar manner as CD3 molecules. Previous studies have shown that TCR a/0 molecules undergo comodulation with CD3 after cell treatment with either anti-TCR or anti-CD3 mAbs (24) . Similar studies performed in both MVl and several CD3+ WT31 -clones indicated that antigen modulation induced by 13133 mAb caused a simultaneous downregulation of surface CD3 molecules. Similarly, mAbinduced CD3 modulation led to the disappearance of 13133-reactive surface antigen (data not shown) . These data strongly suggest that the surface molecules recognized by BB3 mAb in CD3+ WT31 -cells are physically linked to the CD3 molecular complex.
Biochemical Characterization ofProteins Recognized by BB3 mAb. The BB3 mAb immunoprecipitated from 1251 surface-labeled MVl cells an 80-kD surface protein under nonreducing conditions and three bands of -44, 42, and 38 kD under reducing conditions (in the presence of 1% NP-40) (Fig. 2) . Similar figures were obtained from all of the eight additional CD3 + WT31 -BB3+ clones analyzed: in all instances, only disulphide-linked molecules could be precipitated (data not shown) . Under ex- In lane e, cells were lysed in digitonin and immunoprecipitated with BB3 mAb under reducing conditions. FIGURE 3 . NEPHGE analysis of the TCR molecular complex present on the CD3*4-8-WT31 -clone 6.6 .1 . In the left panel, 125 1-labeled 6 .6 .1 cells were lysed under conditions that preserve the CD3TCR complex association (1% digitonin) and were immunoprecipitated with anti-Leu-4 (anti-CD3 mAb). In the right panel, the CD3TCR molecular complex was dissociated by lysing the same cells in buffer containing 1% NP-40 . The lysate was then immunoprecipitated by using the BB3 mAb . Samples were analyzed by NEPHGE . In the second dimension, 11% acrylamide gels were used for SDS-PAGE analysis.
perimental conditions that preserve the TCR/CD3 association (lysis in the presence of 1% digitonin), the BB3 mAb coprecipitated the three bands above together with CD3 molecules. Similar figures were obtained when the same cell lysate was immunoprecipitated with anti-CD3 mAb. The identity between the 44-, 42-, and 38-kD molecules precipitated by BB3 mAb and those precipitated by anti-CD3 mAb was confirmed in two-dimensional electrophoresis experiments (using pH-dependent separation in the first dimension followed by size separation in the second dimension, NEPHGE) (17) . As shown in Fig. 3 , in a BB3* clone, the CD3-associated molecules immunoprecipitated by anti-CD3 mAb displayed the same electrophoretic mobility as the molecules immunoprecipitated by BB3 mAb. It is evident that, in both instances, immunoprecipitated molecules were represented by a 44-kD molecule displaying a basic pI (ti7 .5) and by two more acidic proteins (pI N6) with a mol mass of -42 and 38 kD. Similar data have been reported by Lanier et al. (8) by immunoprecipitation experiments using an anti-CD3 mAb on a CD3' WT31 -cell population . The finding that in immunoprecipitation experiments performed under conditions that do not preserve TCRCD3 interactions (1% NP40) BB3 mAb only precipitated TCR proteins and not CD3 molecules, strongly suggests that the antigenic determinant recognized by BB3 is present on TCR7/8 and not on CD3 molecules.
BB3 mAb Induces CD3' WT31 -Lymphocytes to Express thet'r Functt'onal Program. Previous studies have indicated that CD3'WT31 -cells, similarly to conventional CD3' WT31' (TCRa/P') lymphocytes respond to a series of stimuli including PHA, anti-CD3 mAb, and appropriate combinations of anti-CD2 mAbs (9, 10) . T cell responses resulted in activation of the cellular functional program including lymphokine production and triggering of the lytic machinery. Although the TABLE I IL-2 Production Induced by Anti-CD3 or Anti-TCR-yIS Antibodies 106 /ml cells were cultured in the presence of a final concentration of 1 :20 hybridoma supernatant and 2 ng/ml of PMA . After 24 h supernatants were collected and tested for IL-2 activity using the CTLL indicator system . Data are expressed as arbitrary units of IL-2 activity as described in Materials and Methods. induction of T cell responses by anti-CD3 mAb suggested the existence of a functional activation pathway initiated by CD3/TCR complex, no direct proof existed that the TCRy/S itself was capable of delivering activation signals to the cell . Thus, we investigated whether TCR-y/8' clones, as well as the immunizing MVl cell line, could be triggered by the BB3 mAb to release IL-2. As shown in Table I , three CD3+WT31 -BB3+ clones and the MV1 cell line, which produced IL-2 after stimulation with anti-CD3 mAb, released similar amounts ofIL-2 also after stimulation with 13133 mAb. On the other hand, the remaining clone did not release IL-2 with neither anti-CD3 nor BB3 mAb. Moreover, 13133 mAb failed to activate two Given the ability ofCD3+WT31 -clones and populations to lyse target cells after stimulation with mAbs directed to the CD3/TCR molecular complex (9), we investigated whether activation ofthe lytic machinery could also be induced by BB3 mAb. To this end, we used as triggering target the hybridoma producing BB3 mAb. As shown in Table II , all the CD3+WT31 -BB3+ cells analyzed efficiently lysed the BB3-producing hybridoma as well as an anti-CD3 hybridoma. On the contrary, no lysis occurred when a single anti-CD2 mAb-producing hybridoma (mAb 206) was used. In fact, as previously shown, the activation of the CD2 pathway requires the combined use of suitable anti-CD2 mAbs and does not occur when the signal is given by a single anti-CD2 mAb (25) .
To further define the ability of BB3 mAb to trigger the lytic machinery of TCR y/S+ cells, we used a cytolytic assay in which P815 target cells (which express surface Fc-y receptors) are lysed by CD3 + cytolytic cells provided that soluble anti-CD3 mAb is present (18) . As shown in Table III , BB3 mAb was as efficient as anti-CD3 mAb in inducing lysis of P815 cells by TCRy/S+ clones and MVl cell line. The CD3' WT31' cytolytic clone used as control did not lyse P815 in the presence of BB3 but did so in the presence of WT31 mAb.
We have also investigated the role of free cytoplasmic Cal' levels in the transduction of signals induced after cell stimulation with BB3 mAb. In previous studies (10) we demonstrated that signaling via either CD3 or CD2 surface molecules resulted in a rapid increase of free intracytoplasmic Cal' levels in both CD3 + WT31 -and CD3 + WT31+ lymphocytes . In addition, experiments performed in the presence of the Cal' chelator EGTA indicated that the [Ca2+ ]i raise was consequent to an early release from the internal stores followed by a more sustained Call influx from the extiacellular compartment (10). Here we show that triggering of surface TCR molecules of CD3+WT31 -lymphocytes by BB3 mAb induces a rapid increase of [Ca2+ ] ; levels, followed by a plateau phase (Fig. 4 B) . Similar events occurred when cells were stimulated by anti-CD3 antibodies (Fig. 4 A) . Although not shown, experiments of Cal' mobilization performed in the presence of EGTA confirmed that BB3 More recently, the same group described a second antibody (Ti-YA) directed to the TCRy/8 of adult T lymphocytes (26) . Although no functional data have been reported, Ti-yA mAb appears to be similar to BB3 since it recognized TCRy/8 molecules expressed by the majority of CD3 + WT31 -peripheral lymphocytes and cell clones . However, a remarkable difference between the two antibodies is represented by the reactivity of the Ti-yA antibody with the TCRy/S proteins, independently upon the Cy gene segment used, whereas BB3 reactivity appears to be restricted to cells that express the disulphide-linked form of the TCRy/S . It is noteworthy that the majority of CD3 + WT31 -clones obtained under our experimental conditions displayed the disulphide-linked form of the TCR molecules, in which the y chain is represented by the molecular product of Cyl gene segment (5, 8, 27) , and reacted with BB3 mAb. In contrast, less than one-third expressed the non-disulphide-linked form of the TCR and were not BB3 reactive . In this context, the PEER leukemic cell line, known to express the molecular product of the Cy2 gene (that is non-disulphide-linked to 8 chain) (27) did not react with BB3 mAb. Therefore, the BB3 mAb allows us to further dissect the CD3 + WT31 -cell subset and the two populations so defined may correspond to cells that express different TCRy/S types.
Summary
In an attempt to select mAbs specific for human TCR-y/S, a polyclonal CD3+4-8-WT31 -(TCRy/S+ ) cell line (MVI) was used for mice immunization .
An mAb, termed BB3, reacted with MV1 cells but not with a large panel of CD3' WT3;1' (TCRa/S') cell populations or clones . In addition, BB3 mAb reacted with the majority ofCD3' WT31 -clones derived from six different donors . Doublecolor fluorescence experiments and FACS analysis showed that BB3+ cells were restricted to the CD3+ fraction of peripheral blood lymphocytes; in addition, in several donors the percentages (0.5-8% of total PBL) of BB3+ cells paralleled those of CD3'WT31 -cells. Surface molecules recognized by BB3 were susceptible to antibody-induced modulation ; in addition, cell treatment with either BB3 or anti-CD3 mAb caused the simultaneous downregulation ofthe two molecules. That BB3 molecules are physically linked to CD3 antigen was further supported by immunoprecipitation experiments. Thus, under conditions that preserve the TCR-CD3 association, both BB3 and anti-CD3 mAb precipitated from "'I-labeled MVI cells the same set of molecules. These consisted in the 18-28-kD CD3 molecules and in three bands of -44, 42, and 38 kD under reducing conditions. When cell lysis was performed in 1% NP-40, the molecules immunoprecipitated by BB3 mAb were represented by an 80-kD band under nonreducing conditions, which resolved ; under reducing conditions, in the three 44-, 42-, and 38-kD bands. Similar disulphidelinked forms of the TCR molecules were revealed in all of the other eight CD3' WT31 -BB3+ clones analyzed . Analysis of TCR molecules by electrophoresis (NEPHGE) showed that 13133 or anti-CD3 precipitated a 44-kD molecule displaying a basic PI (-7.5) and two more acidic proteins (PI N6) with a mol mass of 42 and 38 kD. Studies aimed to define whether stimuli directly acting on TCRy/S could induce CD3'WT31 -cell activation revealed that We thank Miss Rosanna Bellomo for technical assistance and Miss Cinzia Miriello for typing the manuscript.
